Over 158 applications for generic products pending with USFDA for approval: Lupin
Sharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last fiscal and saw an increase of 5 per cent on the back of products like Levothyroxine and Oseltamivir. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2020 Category: Pharmaceuticals Source Type: news

Influenza A(H1N2) variant virus – Brazil
On 22 June 2020, the International Health Regualtions (IHR) Focal Point (FP) of Brazil shared a preliminary report with the Panamerican Health Organization, the WHO Regional Office for the Americas of a human infection withInfluenza A(H1N2) variant virus (A(H1N2)v). According to the report, the patient, a 22-year-old female, with no comorbidities, worked in a swine slaughterhouse in Ibipor ã Municipality, Paraná State, and developed an influenza-like illness on 12 April 2020. The patient initially sought medical care on 14 April and a respiratory specimen was obtained on 16 April as part of routine surveillan...
Source: WHO Disease Outbreaks - July 9, 2020 Category: Infectious Diseases Tags: news Source Type: news

Politics, Profits Undermine Public Interest in Covid-19 Vaccine Race
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, May 26 2020 (IPS) With well over five million Covid-19 infections worldwide, and deaths exceeding 340,000, the race for an effective vaccine has accelerated since the SARS-Cov-2 virus was first identified as the culprit. Expecting to score politically from being ‘first’ to have a vaccine, US President Trump’s Operation Warp Speed promises to get 300 million doses to Americans by January, after the November polls, following several failed attempts to monopolize vaccines being developed by European companies. Anis Chowdhury More than 115 vac...
Source: IPS Inter Press Service - Health - May 26, 2020 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Aid Economy & Trade Featured Global Headlines Health Humanitarian Emergencies TerraViva United Nations Jomo Kwame Sundaram & Anis Chowdhury Source Type: news

Potential Effectiveness and Safety of Antiviral Agents in Children with Coronavirus Disease 2019: A Rapid Review and Meta-Analysis, MedRxiv, 2020
Conclusions: There is no evidence showing the effectiveness of antiviral agents for children with COVID-19, and the clinical efficacy of existing antiviral agents is still uncertain. We do not suggest clinical routine use of antivirals for COVID-19 in children, with the exception of clinical trials. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 24, 2020 Category: Consumer Health News Source Type: news

Miraculous medicines are always more myth than reality: Pandemics, prophylactics and pice packets
Oseltamivir was that drug during bird flu several years back, and hydroxychloroquine (HCQ) is the drug today. President Trump ’s demands for a quick solution, and refusal to listen to medical experts, caused soaring demand and pressure put on India, which has stocks, to supply the US, even as concerns rise about our own supply. (Source: The Economic Times)
Source: The Economic Times - April 17, 2020 Category: Consumer Health News Source Type: news

FDA accepts Roche ’s New Drug Application for Xofluza (baloxavir marboxil) for the treatment of influenza in children
Basel, 27 March  2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) as well as two supplemental New Drug Applications (sNDA) for Xofluza® (baloxavir marboxil). The FDA accepted a NDA for a new formulation of Xofluza as one-dose granules for oral suspension (2 mg/mL), potentially offering a more convenient option for children and those who have difficulty swallowing. In addition, the application seeks approval of Xofluza for the treatment of acute uncomplicated influenza in otherwise healthy children aged one to l ess th...
Source: Roche Investor Update - March 27, 2020 Category: Pharmaceuticals Source Type: news

Partygoers in Seattle, a Suburban D.C. Mom: Coronavirus in the Community
What doctors are learning about Covid-19 in the community. (Source: NYT Health)
Source: NYT Health - March 18, 2020 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Coronavirus (2019-nCoV) Tests (Medical) Quarantines Tamiflu (Drug) Influenza SARS (Severe Acute Respiratory Syndrome) Epidemics Coughs Hospitals Deaths (Fatalities) Fever Source Type: news

First Coronavirus Death in New Jersey: Yonkers Raceway Worker
The 69-year-old man is believed to be the first person in the Northeast whose death was related to the virus. (Source: NYT Health)
Source: NYT Health - March 11, 2020 Category: Consumer Health News Authors: Tracey Tully Tags: Coronavirus (2019-nCoV) Tamiflu (Drug) Hackensack University Medical Center Murphy, Philip D (1957- ) Oliver, Sheila Y Bergen County (NJ) Deaths (Fatalities) Source Type: news

First Coronavirus Death in New Jersey Is 69-Year-Old Man
The man, who lived about 20 miles northwest of Manhattan, is believed to be the first person from the Northeast whose death was related to the virus. (Source: NYT Health)
Source: NYT Health - March 11, 2020 Category: Consumer Health News Authors: Tracey Tully Tags: Coronavirus (2019-nCoV) Tamiflu (Drug) Hackensack University Medical Center Murphy, Philip D (1957- ) Oliver, Sheila Y Bergen County (NJ) Deaths (Fatalities) Source Type: news

Coronavirus: Ten Reasons Why You Ought Not to Panic
This article is republished from The Conversation. Read the original article. The post Coronavirus: Ten Reasons Why You Ought Not to Panic appeared first on Inter Press Service. Excerpt: Ignacio López-Goñi is microbiologist and works in University of Navarra (Spain). The post Coronavirus: Ten Reasons Why You Ought Not to Panic appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - March 7, 2020 Category: International Medicine & Public Health Authors: Ignacio Lopez Goni Tags: Global Headlines Health Coronavirus Source Type: news

Boy dies of flu after mom seeks advice from anti-vax Facebook group
In a heartbreaking post, his mother says the child's doctor prescribed him Tamiflu, but she never picked it up. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 7, 2020 Category: Consumer Health News Source Type: news

Boy, 4, dies of flu after anti-vaxxers told mother not to use Tamiflu
A Colorado mother asked advice for 'treating' her four-year-old son with flu symptoms in the Facebook group Stop Mandatory Vaccines. She never picked up Tamiflu and the boy died days later. (Source: the Mail online | Health)
Source: the Mail online | Health - February 7, 2020 Category: Consumer Health News Source Type: news

Flu Patients Get Better Sooner With Oseltamivir, Pragmatic Trial Shows Flu Patients Get Better Sooner With Oseltamivir, Pragmatic Trial Shows
A study from Europe provides estimates of the likely benefits of adding oseltamivir to usual care for patients with influenza-like illness.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 21, 2019 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Two Drugs Better Than One for Severe Influenza Two Drugs Better Than One for Severe Influenza
Favipiravir and oseltamivir were more effective for severe influenza than oseltamivir alone, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 16, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Sanofi makes deal for Tamiflu rights from Roche
The deal will give Sanofi exclusive OTC rights to the flu treatment in the U.S. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 23, 2019 Category: Pharmaceuticals Source Type: news

Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu
French drugs and healthcare group Sanofi said on Tuesday it had signed a rights deal with Roche for the 'Tamiflu' product in the United States. (Source: Reuters: Health)
Source: Reuters: Health - July 23, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Roche says one-dose Xofluza flu drug as good as older Tamiflu in kids
Swiss drugmaker Roche said its new one-dose flu medicine Xofluza was comparable to its 20-year-old drug Tamiflu in reducing the duration of symptoms of the viral disease, citing a study of the drug in children aged one to 12 years old. (Source: Reuters: Health)
Source: Reuters: Health - July 3, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Drug Safety Communication: Important safety changes to the influenza drug Tamiflu (oseltamivir phosphate) for oral suspension
On 7/11/2011, the U.S. Food and Drug Administration (FDA) informed the public of important product safety changes to the influenza drug Tamiflu (oseltamivir phosphate) for oral suspension. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 28, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Medical News Today: What are the side effects of Tamiflu in children?
Tamiflu is a prescription drug that doctors sometimes use to treat the influenza, or flu, virus. In this article, learn about the possible side effects and risks in children. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2019 Category: Consumer Health News Tags: Pediatrics / Children's Health Source Type: news

Reasonable Doubt: Don't Be Fooled by New Study: Tamiflu Still Pretty Worthless for H1N1
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - April 1, 2019 Category: Emergency Medicine Tags: Reasonable Doubt Source Type: news

CDC: Flu Season May Not Have Peaked, Another Wave Of Severe Infections Underway
(CNN) — Flu activity remains high across the nation, and there’s a second wave of severe infections striking some states. There were as many as 26.3 million flu illnesses, 12.4 million medical visits and 347,000 flu hospitalizations between October 1 and March 2, according to the weekly flu report released Friday by the US Centers for Disease Control and Prevention. “We’re still having flu. And we’re still seeing a steady stream of patients who are being admitted to hospital with influenza,” said Dr. William Schaffner, medical director of the National Foundation for Infectious Diseases. ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 8, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Flu Source Type: news

Earlier Oseltamivir May Cut Death Risk in Influenza A/H3N2 (CME/CE)
(MedPage Today) -- No effect on mortality was observed for H1N1 and influenza B patients (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 19, 2019 Category: Primary Care Source Type: news

This Year ’ s Flu Shot Less Than 50% Effective, According To CDC
By Susan Scutti, CNN (CNN) — Don’t let your guard down: The US flu season is expected to continue for several more weeks, with activity across the nation now elevated, the US Centers for Disease Control and Prevention reported Thursday. A flu shot is still recommended for those who have neglected to get one, but the CDC estimated this year’s vaccine’s overall effectiveness in preventing an infection at just 47%. The shot’s success varies based on your age, the CDC noted. Among children up to 17, its overall effectiveness against flu was 61%, while just 24% of adults 50 and older who received t...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 14, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Flu Flu Shot Source Type: news

Earlier Tamiflu May Cut Death Risk in Some Severe Cases
(MedPage Today) -- Observed 30% decrease in mortality with early oseltamivir among influenza A/H3N2 patients in ICU (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 13, 2019 Category: American Health Source Type: news

My High-risk Flu Patients Get Antibiotics, and Here ’s Why
Of course they get oseltamivir--but our author has been adding azithromycin for his high-risk patients since the 2015-16 season. He explains why. (Source: ConsultantLive)
Source: ConsultantLive - January 23, 2019 Category: Internal Medicine Authors: C. Andrew Schroeder, MD Tags: Respiratory Diseases Source Type: news

Flu Cases on Upswing as New Medicine Arrives
A new drug to treat flu, Xofluza, is now available to pharmacies nationwide. It joins Tamiflu, the most commonly prescribed treatment. (Source: WebMD Health)
Source: WebMD Health - January 7, 2019 Category: Consumer Health News Source Type: news

Flu Treatments: What's New and What's for You
During last year’s bad flu season, so many people were trying to get Tamiflu that some areas had shortages. (Source: WebMD Health)
Source: WebMD Health - November 27, 2018 Category: Consumer Health News Source Type: news

Flu symptoms can be eliminated naturally without the need for toxic drugs
(Natural News) Battling flu symptoms is never a good time, but conventional medicines often leave much to be desired. Even the “gold standard” of flu medicines, Tamiflu, is said to shorten the duration of illness by one day — at most — and that’s on top of the fact that some 99 percent of viral... (Source: NaturalNews.com)
Source: NaturalNews.com - November 27, 2018 Category: Consumer Health News Source Type: news

Personal Health: Need a Flu Shot? Get It Now
Immunity tends to wane by 20 percent a month, leaving those who got their shot in August or September with less than desirable protection by the time they ’ re exposed. (Source: NYT Health)
Source: NYT Health - November 5, 2018 Category: Consumer Health News Authors: JANE E. BRODY Tags: Influenza Vaccination and Immunization Tamiflu (Drug) Relenza (Drug) Viruses Epidemics Source Type: news

The New Anti-Flu Drug Xofluza's Value Proposition
An improved clinical benefit profile together with the potential for diminished physician service and hospital spending appear to justify the Xofluza's price premium relative to Tamiflu. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 1, 2018 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news

F.D.A. Approves New Drug for Flu
The new drug, sold as Xofluza, is about as effective as Tamiflu in shortening flu symptoms, and is expected to work against drug-resistant strains. (Source: NYT Health)
Source: NYT Health - October 24, 2018 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Influenza Drugs (Pharmaceuticals) Tamiflu (Drug) Gottlieb, Scott (1972- ) Genentech Inc Shionogi Xofluza Source Type: news

The FDA Approved a New Flu Treatment, Just In Time for Flu Season
The Food and Drug Administration (FDA) has approved a new antiviral influenza treatment. The agency on Wednesday approved Genentech’s drug Xofluza, which can be taken via a single oral dose to help patients recover more quickly from the flu. It’s the “first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years,” FDA Commissioner Dr. Scott Gottlieb said in a statement. The main factor differentiating Xofluza from other antiviral flu treatments on the market, such as Tamiflu and Relenza, is the way it’s taken. Xofluza is the only antiviral that can b...
Source: TIME: Health - October 24, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthytime onetime Source Type: news

FDA Approves First-in-Class Flu Drug
(MedPage Today) -- Baloxavir at least as effective as oseltamivir (Tamiflu) in clinical trials, with different mechanism (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 24, 2018 Category: American Health Source Type: news

Here ’s How to Tell if You Have a Cold or the Flu
Your nose is dripping like a leaky faucet, your throat is sore and you can’t stop sneezing. You don’t have a fever, but you feel wiped out—like you could curl up on the floor and fall asleep. Do you have a cold or the flu? If you guessed cold, you’re probably right. But experts say that differentiating the common cold (an upper respiratory infection) from the flu (influenza) can be trickier than most people assume. “There is huge overlap among non-influenza viruses and the symptoms produced by influenza and other bugs,” says Dr. Bruce Barrett, a professor of family medicine and community...
Source: TIME: Health - October 11, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized public health Source Type: news

More Evidence That Baloxavir Reduces Flu Symptom Duration
(MedPage Today) -- Investigational antiviral matches or exceeds efficacy of oseltamivir (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - October 9, 2018 Category: Infectious Diseases Source Type: news

New Flu Drug Cuts Time to Recovery New Flu Drug Cuts Time to Recovery
The single-dose agent is safe and effective and has a shorter viral shedding time than oseltamivir, according to results from CAPSTONE 2, which could play a role in the drug's approval by year end.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 7, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

New One-Dose Flu Drug Shows Promise
The study also found it as effective as the current standard drug, oseltamivir (Tamiflu), at controlling symptoms such as coughing, sore throat, headache, fever, muscle and joint pain, and fatigue. (Source: WebMD Health)
Source: WebMD Health - September 6, 2018 Category: Consumer Health News Source Type: news

Baloxavir Reduces Flu Symptoms and Viral Shedding Baloxavir Reduces Flu Symptoms and Viral Shedding
The first-in-class antiviral drug reduced duration of influenza symptoms and viral shedding compared with both placebo and oseltamivir in phase 2 and phase 3 randomized trials.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 5, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Baloxavir Cuts Median Length of Flu Symptoms
(MedPage Today) -- But relief no faster than with Tamiflu (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - September 5, 2018 Category: Infectious Diseases Source Type: news

Roche Touts New Flu Drug as Tamiflu Suffers Generics Hit Roche Touts New Flu Drug as Tamiflu Suffers Generics Hit
Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 18, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Roche single-dose flu med finds success for people at high risk of complications
Baloxavir marboxil, the company's Tamiflu replacement, had previously shown only modest benefits in older studies (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 17, 2018 Category: Pharmaceuticals Source Type: news

Roche touts new flu drug as Tamiflu suffers generics hit
Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications. (Source: Reuters: Health)
Source: Reuters: Health - July 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche lauds new flu drug trial as Tamiflu suffers generics hit
Swiss drugmaker Roche's hopes of regaining ground in the influenza market have been boosted after a late-stage study showed its investigational drug baloxavir marboxil reduced symptoms in people at high risk of complications. (Source: Reuters: Health)
Source: Reuters: Health - July 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

What Causes Hyponatremia?
Discussion Normal kidneys regulate water balance to maintain a plasma osmolality of 275-290 mOsm/kg normally. Thirst and arginine vasopressin or antidiuretic hormone (ADH) are the primary regulators of plasma osmolality. ADH is made in the hypothalamus and released by the posterior pituitary gland. ADH acts on the kidney’s distal collecting duct to increase water reabsorption. ADH is appropriately released in hypovolemic states, such as dehydration caused by gastroenteritis. ADH has an ~10 minute half-life and therefore can respond to rapid changes in volume status. Sodium balance is regulated by aldosterone (as part...
Source: PediatricEducation.org - April 23, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

The relationship between oseltamivir and suicide in pediatric patients - Harrington R, Adimadhyam S, Lee TA, Schumock GT, Antoon JW.
PURPOSE: Studies examining the association between use of oseltamivir and neuropsychiatric events (including suicide) among children have had mixed findings and have been limited by small sample size, reliance on older data, and potential confounding. We u... (Source: SafetyLit)
Source: SafetyLit - March 19, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Study Debunks Link Between Tamiflu & Teen Suicide
Since 2006, the U.S. Food and Drug Administration has required a warning on Tamiflu packaging that it may cause hallucinations and delirium in young patients and make them more apt to hurt themselves or take their own lives. (Source: WebMD Health)
Source: WebMD Health - March 16, 2018 Category: Consumer Health News Source Type: news

Study Debunks Link Between Tamiflu and Teen Suicide
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - March 16, 2018 Category: Psychiatry Tags: Infections, Pediatrics, Pharmacy, Psychiatry, News, Source Type: news

Study Debunks Link Between Tamiflu and Teen Suicide
FRIDAY, March 16, 2018 -- Finally, there's a bit of positive news in this brutal flu season. A new study suggests that Tamiflu (oseltamivir), the only commercially available prescription medicine approved to treat the flu, does not boost suicide... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 16, 2018 Category: General Medicine Source Type: news

Study debunks fears of increased teen suicide risk from popular flu drug
(University of Illinois at Chicago) A new study published by researchers from the University of Illinois at Chicago suggests that the drug oseltamivir -- commonly known as Tamiflu -- does not cause an increased risk of suicide in pediatric patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 13, 2018 Category: Infectious Diseases Source Type: news